Specific Expression of Human c-fgr in Natural Immunity Effector Cells

Literature Cited

• Adachi, A., H. E. Gendelman, S. Koenig, T. Folks, R. Willey, A. Rabson, and M. A. Martin. 1986. Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone. J. Virol. 59:284–291.
   PubMed Web of Science ®Google Scholar
• Akiyama, T., C. Sudo, H. Ogawara, K. Toyoshima, and T. Yamamoto. 1986. The product of the human c-erbB-2 gene: a 185 kilodalton glycoprotein with tyrosine kinase activity. Science 232:1644–1646.
   PubMed Web of Science ®Google Scholar
• Amrein, P. C., and T. P. Stossel. 1980. Prevention of degradation of human polymorphonuclear leukocyte proteins by diisopropylfluorophosphate. Blood 56:442–447.
   PubMedGoogle Scholar
• Birnboim, H. C. 1988. Rapid extraction of high molecular weight RNA from cultured cells and granulocytes for Northern analysis. Nucleic Acids Res. 16:1487–1497.
   PubMed Web of Science ®Google Scholar
• Breitman, T. R., S. E. Selonick, and S. J. Collins. 1980. Induction of differentiation of the human promyelocytic leukemia cell line (HL-60) by retinoic acid. Proc. Natl. Acad. Sci. USA 77:2936–2940.
   PubMed Web of Science ®Google Scholar
• Cheah, M. S. C., T. J. Ley, S. R. Tronick, and K. C. Robbins. 1986. fgr proto-oncogene mRNA induced in B-lymphocytes by Epstein-Barr virus infection. Nature (London) 319:238–240.
   PubMed Web of Science ®Google Scholar
• Collins, S. J., R. C. Gallo, and R. E. Gallagher. 1977. Continuous growth and differentiation of human myeloid leukaemic cells in suspension culture. Nature (London) 270:347–349.
   PubMed Web of Science ®Google Scholar
• Collins, S. J., F. W. Ruscetti, R. E. Gallagher, and R. C. Gallo. 1978. Terminal differentiation of human promyelocytic leukemia cells induced by dimethyl sulfoxide and other polar compounds. Proc. Natl. Acad. Sci. USA 75:2458–2462.
   PubMed Web of Science ®Google Scholar
• Harris, P., and P. Ralph. 1985. Human leukemic models of myelomonocytic development: a review of the HL-60 and U937 cell lines. J. Leukocyte Biol. 37:407–422.
   PubMed Web of Science ®Google Scholar
• Hercend, T., and R. E. Schmidt. 1988. Characteristics and uses of natural killer cells. Immunol. Today 9:291–293.
   PubMedGoogle Scholar
• Hilios, R. R. 1984. A simple method of obtaining monocytes in suspension. J. Immunol. Methods 69:71–77.
   PubMedGoogle Scholar
• Inoue, K., S. Ikawa, K. Semba, J. Sukegawa, T. Yamamoto, and K. Toyoshima. 1987. Isolation and sequencing of cDNA clones homologous to the v-fgr oncogene from a human B lymphocyte cell line, IM-9. Oncogene 1:301–304.
   PubMedGoogle Scholar
• Junqueira, L. C., J. Carneiro, and A. N. Contopoulos. 1977. Blood cells, p. 228–243. In Basic histology. Lange Medical Publications, Maruzen Co. Ltd., Tokyo.
   Google Scholar
• Katamine, S., V. Notario, C. D. Rao, T. Miki, M. S. C. Cheah, S. R. Tronick, and K. C. Robbins. 1988. Primary structure of the human fgr proto-oncogene product p55c-fgr. Mol. Cell. Biol. 8:259–266.
   PubMedGoogle Scholar
• Ley, T. J., N. L. Connolly, S. Katamine, M. S. C. Cheah, R. M. Senior, and K. C. Robbins. 1989. Tissue-specific expression and developmental regulation of the human fgr proto-oncogene. Mol. Cell. Biol. 9:92–99.
   PubMedGoogle Scholar
• Naharro, G., K. C. Robbins, and E. P. Reddy. 1984. Gene product of v-fgr one: hybrid protein containing a portion of actin and a tyrosine-specific protein kinase. Science 223:63–66.
   PubMed Web of Science ®Google Scholar
• Naharro, G., S. R. Tronick, S. Rasheed, M. B. Gardner, S. A. Aaronson, and K. C. Robbins. 1983. Molecular cloning of intergrated Gardner-Rasheed feline sarcoma virus: genetic structure of its cell-derived sequence differs from that of other tyrosine kinase-coding one genes. J. Virol. 47:611–619.
   PubMedGoogle Scholar
• Nishizawa, M., K. Semba, T. Yamamoto, and K. Toyoshima. 1985. Human c-fgr gene does not contain coding sequence for actin-like protein. Jpn. J. Cancer Res. 76:155–159.
   PubMedGoogle Scholar
• Notario, V., J. S. Gutkind, M. Imaizumi, S. Katamine, and K. C. Robbins. 1989. Expression of the fgr protooncogene product as a function of myelomonocytic cell maturation. J. Cell Biol. 109:3129–3136.
   PubMed Web of Science ®Google Scholar
• Ortaldo, J. R. 1987. Regulation of natural killer activity. Cancer Metastasis Rev. 6:637–651.
   PubMed Web of Science ®Google Scholar
• Oshimi, K., Y. Oshimi, M. Satake, and H. Mizoguchi. 1985. Natural killer-mediated lysis of normal and malignant target cells, and its regulation by monocytes. J. Exp. Med. 162:472–486.
   PubMed Web of Science ®Google Scholar
• Rudd, C. E., J. M. Trevillyan, J. D. Dasgupta, L. L. Wong, and S. F. Schlossman. 1988. The CD4 receptor is complexed in detergent lysates to a protein-tyrosine kinase (pp58) from human T lymphocytes. Proc. Natl. Acad. Sci. USA 85:5190–5194.
   PubMed Web of Science ®Google Scholar
• Takeya, T., and H. Hanafusa. 1983. Structure and sequence of the cellular gene homologous to the RSV src gene and the mechanism for generating the transforming virus. Cell 32:881–890.
   PubMed Web of Science ®Google Scholar
• Timonen, T., J. R. Ortaldo, and R. B. Herberman. 1981. Characteristics of human large granular lymphocytes and relationship to natural killer and K cells. J. Exp. Med. 153:569–582.
   PubMed Web of Science ®Google Scholar
• Veillette, A., M. A. Bookman, E. M. Horak, and J. B. Bolen. 1988. The CD4 and CD8 T cell surface antigens are associated with the internal membrane protein-tyrosine kinase p56lrA. Cell 55:301–308.
   PubMed Web of Science ®Google Scholar